Skip to main content
. 2022 Mar 2;10(3):465. doi: 10.3390/healthcare10030465

Figure 3.

Figure 3

Average usage per day (minutes) and compliance (≥4 h usage day %) in controls at two time points: 30 days before (baseline) and 30 days after the telemonitoring phase (control). Wilcoxon—Rank test was used to compare the group. * p value ≤ 0.05 was considered to be significant.